Svenja Tatjana Barckhausen: From Plasma Dependence to Self-Sufficiency in Africa
Svenja Tatjana Barckhausen, CEO and Founder of Blood Plasma Strategy Experts, shared a post on LinkedIn:
“Africa is still undersupplied with erythrocytes and plasma derived medicinal products (pdmP).
Improvement is possible and the potential is huge to become self-sufficient and strengthen access to care through own efforts.
African nations can hardly afford pdmP’s made from expensive US plasma that accounts for more than 70 percent of global plasma collection.
As a result, too many patients remain untreated.
Countries can rise from dependence to independence by collecting enough plasma for fractionation.
By strengthening local collection, countries can move from dependence on costly imports toward true independence and sustainable access to care.
Encouragingly, during the AfSBT Congress in Namibia this March, where I had the privilege to participate, I sensed a shift: awareness is growing that local collection of blood and plasma for fractionation is not just important — it’s essential for the continent’s future healthcare resilience.
Several models were discussed by different speaker and high level attendees such like the minister of health of Namibia, representatives from European blood banks and governments as well as the WHO had representative attending.
One immediate step is to make Recovered Plasma from whole‑blood donations available for fractionation.
Beyond that, introducing plasmapheresis and establishing sustainable plasma collection will be essential to achieving plasma product independence across the continent.
This approach benefits everyone: blood banks can reinvest proceeds from plasma utilization to strengthen their national transfusion services.
Introducing plasmapheresis and sustainable plasma collection systems will not only improve access to PDMPs but also drive Africa toward self-sufficiency.
Importantly, each country should be empowered to choose its own path — whether developing national fractionation facilities or creating regional collaborations that fit their healthcare and political realities.
Several nations have already started demonstrating that this goal is achievable.
Egypt has already shown that establishing plasmapheresis programs is possible in Africa.
Namibia’s initiative to use its Recovered Plasma is another strong example – a small but powerful step toward greater access to care across the continent.
The vision is clear: Africa can produce its own plasma for fractionation to build resilient, independent, and sustainable access to care.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session